A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Shibasaki T, Koyama A, Hishida A, Muso E, Osawa G, Yamabe H, Shiiki H, Makino H, Sato H, Ishikawa I, Maeda K, Tomita K, Arakawa M, Ishida M, Sato M, Nagase M, Kashihara N, Yorioka N, Koike T, Saito T, Harada T, Mitarai T, Sugisaki T, Nagasawa T, Tomino Y, Nojima Y, Kobayashi Y, Sakai O.
Shibasaki T, et al. Among authors: sato h, sato m.
Clin Exp Nephrol. 2004 Jun;8(2):117-26. doi: 10.1007/s10157-004-0276-0.
Clin Exp Nephrol. 2004.
PMID: 15235928
Clinical Trial.